General Information of the Compound
Compound ID
CP0949720
Compound Name
(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-6-amino-2-{[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,51S,54S,57S,60R,65R,68S,71S,74S)-21-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-27,57-bis(4-aminobutyl)-54,74-bis(3-carbamimidamidopropyl)-24-(2-carbamoylethyl)-13-(2-carboxyethyl)-45-(carboxymethyl)-39-[(1R)-1-hydroxyethyl]-48-(hydroxymethyl)-30,36,68-tris(1H-indol-3-ylmethyl)-51-methyl-7,71-bis(2-methylpropyl)-33-[2-(methylsulfanyl)ethyl]-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,67,70,73,76,81-tricosaoxo-4-(propan-2-yl)-18,19,62,63,78,79-hexathia-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,66,69,72,75,82-tricosaazatricyclo[40.34.4.2^{16,60}]dooctacontan-65-yl]formamido}hexanamido]hexanamido]hexanamido]-3-methylpentanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid
    Show/Hide
Structure
Formula
C173H261N47O40S7
Molecular Weight
3863.749
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CSSC[C@@H]2NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]3CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](N)Cc4ccc(O)cc4)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)N[C@@H]([C@@H](C)O)C(=O)N3)NC2=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O
    Show/Hide
InChI
InChI=1S/C173H261N47O40S7/c1-14-92(10)140(169(257)209-122(69-90(6)7)155(243)210-127(171(259)260)74-99-79-190-109-42-22-18-38-104(99)109)219-153(241)114(47-27-32-63-178)198-145(233)110(43-23-28-59-174)195-146(234)111(44-24-29-60-175)199-163(251)130-83-263-265-85-132-167(255)215-131-84-264-262-82-129(212-143(231)105(179)70-95-50-52-100(223)53-51-95)162(250)202-118(54-56-135(180)224)151(239)197-112(45-25-30-61-176)148(236)205-123(71-96-76-187-106-39-19-15-35-101(96)106)156(244)203-119(58-66-261-13)152(240)206-125(73-98-78-189-108-41-21-17-37-103(98)108)160(248)220-141(94(12)222)170(258)217-134(166(254)208-126(75-138(228)229)158(246)211-128(81-221)161(249)192-93(11)142(230)194-115(48-33-64-185-172(181)182)147(235)196-113(150(238)213-132)46-26-31-62-177)87-267-266-86-133(216-168(256)139(91(8)9)218-159(247)120(67-88(2)3)193-136(225)80-191-144(232)117(201-164(131)252)55-57-137(226)227)165(253)200-116(49-34-65-186-173(183)184)149(237)204-121(68-89(4)5)154(242)207-124(157(245)214-130)72-97-77-188-107-40-20-16-36-102(97)107/h15-22,35-42,50-53,76-79,88-94,105,110-134,139-141,187-190,221-223H,14,23-34,43-49,54-75,80-87,174-179H2,1-13H3,(H2,180,224)(H,191,232)(H,192,249)(H,193,225)(H,194,230)(H,195,234)(H,196,235)(H,197,239)(H,198,233)(H,199,251)(H,200,253)(H,201,252)(H,202,250)(H,203,244)(H,204,237)(H,205,236)(H,206,240)(H,207,242)(H,208,254)(H,209,257)(H,210,243)(H,211,246)(H,212,231)(H,213,238)(H,214,245)(H,215,255)(H,216,256)(H,217,258)(H,218,247)(H,219,241)(H,220,248)(H,226,227)(H,228,229)(H,259,260)(H4,181,182,185)(H4,183,184,186)/t92-,93-,94+,105-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,139-,140-,141-/m0/s1
    Show/Hide
InChIKey
NUDCOUZYTPRIML-AXCGLNHNSA-N
Physicochemical Property
logP
-5.63396
Rotatable Bonds
75
Heavy Atom Count
267
Polar Areas
1431.76
Hydrogen Bond Donor Count
53
Hydrogen Bond Acceptor Count
52
Complexity
267

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118708668
ChEMBL ID
CHEMBL3318138
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04059, Sodium channel protein type 2 subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 33 nM
   TI
   LI
   LO
   TS
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS